This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Austin SR , Wong YN , Uzzo RG , Beck JR , Egleston BL
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
Med Care. 2015 Sep;53(9) :e65-72
PMID: 23703645 URL: http://www.ncbi.nlm.nih.gov/pubmed/23703645
AbstractBACKGROUND: Comorbidity adjustment is an important component of health services research and clinical prognosis. When adjusting for comorbidities in statistical models, researchers can include comorbidities individually or through the use of summary measures such as the Charlson Comorbidity Index or Elixhauser score. We examined the conditions under which individual versus summary measures are most appropriate. METHODS: We provide an analytic proof of the utility of comorbidity summary measures when used in place of individual comorbidities. We compared the use of the Charlson and Elixhauser scores versus individual comorbidities in prognostic models using a SEER-Medicare data example. We examined the ability of summary comorbidity measures to adjust for confounding using simulations. RESULTS: We devised a mathematical proof that found that the comorbidity summary measures are appropriate prognostic or adjustment mechanisms in survival analyses. Once one knows the comorbidity score, no other information about the comorbidity variables used to create the score is generally needed. Our data example and simulations largely confirmed this finding. CONCLUSIONS: Summary comorbidity measures, such as the Charlson Comorbidity Index and Elixhauser scores, are commonly used for clinical prognosis and comorbidity adjustment. We have provided a theoretical justification that validates the use of such scores under many conditions. Our simulations generally confirm the utility of the summary comorbidity measures as substitutes for use of the individual comorbidity variables in health services research. One caveat is that a summary measure may only be as good as the variables used to create it.
NotesAustin, Steven R Wong, Yu-Ning Uzzo, Robert G Beck, J Robert Egleston, Brian L ENG P30 CA006927/CA/NCI NIH HHS/ R03 CA152388/CA/NCI NIH HHS/ P30CA006927/CA/NCI NIH HHS/ R03CA152388/CA/NCI NIH HHS/ Research Support, N.I.H., Extramural 2013/05/25 06:00 Med Care. 2015 Sep;53(9):e65-72. doi: 10.1097/MLR.0b013e318297429c.